ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1256

High Inflammation May Condition the Antiatherogenic Function of Small, Dense HDL in Patients with Active Rheumatoid Arthritis

Carla Saucedo1, Leonardo gomez Rosso2, Tomas Meroño2, Fernando Brites2, Anatol Kontush3, Luis J. Catoggio4, Enrique Soriano4, Laurent Camont5, Marie Lhomme5, Veronica Malah6, Patricia Sorroche7, Sandrine Chantepie5, Paul Robillard8 and John Chapman5, 1Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2University of Buenos Aires, Laboratory of Lipids and Lipoproteins, School of Pharmacy and Biochemistry, Buenos Aires, Argentina, 3Université Pierre et Marie Curie-Paris, Paris, France, 4Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 5Université Pierre et Marie Curie, Paris, France, 6Rheumatology section, Hospital de Clínicas “José de San Martín”, Buenos Aires, Argentina, 7Central Laboratory , Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 8Université Pierre et Marie Curie, Paris, Argentina

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cholesterol and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects II: Clinical Features & Comorbidity/Cardiovascular Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is associated with increased mortality, mainly due to cardiovascular disease.  High grade inflammation might drive to premature atherosclerosis. High-density lipoprotein (HDL) possesses multiple biological activities, including antioxidative actions. Small, dense HDL3c particles exert potent antiatherogenic activities, which can be compromised under conditions of chronic inflammation. It remains indeterminate as to whether the level of such functional HDL deficiency is related to the degree of inflammation. Our objective was to evaluate HDL antioxidative function in normolipidemic RA active patients and controls.

Methods: serum from normolipidemic female patients with active RA (DAS28 >3.2; n=12) and normolipidemic age-matched female controls (n=10) was analized. Plasma levels of total cholesterol (TC), triglycerides (TG), HDL, LDL, apo-A, apo-B, plasma C-reactive protein (PCR), and serum amyloid A (SAA), subfractions of LDL and HDL were obtained.  Small, dense HDL3b and 3c particles were isolated by density gradient ultracentrifugation.  The capacity to protect LDL from oxidative stress induced by free radicals was assessed in small, dense HDL3b and HDL3c subpopulations, and in total HDL.

Results: sera from 12 active female RA patients and 10 age-matched female controls were analized. No significant differences were observed in plasma levels of TC, TG, LDL, HDL, apo-A and apo-B. Active RA patients exhibited a wide range of plasma C-reactive protein (CRP) levels, which were elevated relative to controls (8.4 mg/l, CI 3.5-11.4 vs. 0.47 mg/l, CI 0.30-0.89, p<0.001). Antioxidative activity and total chemical composition of small, dense HDL did not differ between RA patients and controls (p>0.05). Nonetheless, subgroup analyses revealed that RA patients featuring high levels of inflammation (CRP>10mg/l) possessed small, dense HDL with reduced antioxidative activities (up to -23%, p<0.01). Furthermore, antioxidative activity of HDL was inversely correlated with plasma CRP and SAA levels. HDL3b and 3c were depleted of free cholesterol (FC) in high-inflammated RA patients. This FC depleted HDL particles were less efficient in preventing LDL oxidation. 

Conclusion: only RA patients who displayed high circulating levels of inflammatory biomarkers (CRP and SAA) possessed small, dense HDL3 particles with reduced antioxidative activity.  This reduction in antioxidative action of HDL3 particles, along with reduced capacity of HDL to promote cholesterol efflux, and depletion of free cholesterol in HDL, may enhance development of atherosclerosis in active RA patients. These pathophysiological features are intimately linked to the inflammatory state, supporting that uncontrolled chronic inflammation leads to increased cardiovascular risk.


Disclosure:

C. Saucedo,

Qualitas,

2;

L. gomez Rosso,
None;

T. Meroño,
None;

F. Brites,
None;

A. Kontush,
None;

L. J. Catoggio,
None;

E. Soriano,
None;

L. Camont,
None;

M. Lhomme,
None;

V. Malah,
None;

P. Sorroche,
None;

S. Chantepie,
None;

P. Robillard,
None;

J. Chapman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-inflammation-may-condition-the-antiatherogenic-function-of-small-dense-hdl-in-patients-with-active-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology